ReCode Therapeutics
Menlo Park, CA
ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases.
recodetx.comCompany Details
Founded
- 2015
Employees
- Between 10 - 200 employees
Raised
- $357,000,000
Headquarters Location
- Menlo Park, CA
Public
- No
Acquired
- No
CEO
Shehnaaz Suliman
Founders
- Philip ThomasDaniel SiegwartMichael Torres
Company Collections
These are collections ReCode Therapeutics is a part of. Click on the collection name to view similar companies.
ReCode Therapeutics' Industries
Current Job Listings
Listing 0 of 1 job openings
ReCode Therapeutics Headquarters Location
1140 Obrien Dr, Menlo Park, CA 94025
Total Amount Raised: $357,000,000
ReCode Therapeutics Funding Rounds
Series Unknown
$15,000,000
Series Unknown Investors
Cystic Fibrosis FoundationSeries B
$50,000,000
Series B Investors
Bioluminescence VenturesMatrix Capital ManagementVida VenturesSolasta VenturesMPM CapitalLeaps by BayerSanofi-AventisPfizer Venture InvestmentsAmgenEcoR1 CapitalOsage University Partners IIOrbiMed AdvisorsSeries Unknown
$10,000,000
Series Unknown Investors
Cystic Fibrosis FoundationSeries B
$120,000,000
Series B Investors
Leaps by BayerMatrix Capital ManagementAmgenSanofi-AventisPfizer Venture InvestmentsSeries B
$80,000,000
Series B Investors
EcoR1 CapitalPfizer Venture InvestmentsMPM CapitalSuperstring CapitalTekla Capital ManagementOsage University Partners IINS InvestmentOrbiMed AdvisorsSanofi-AventisVida VenturesColt VenturesSeries A
$80,000,000
Series A Investors
Colt VenturesOrbiMed AdvisorsVida VenturesMPM CapitalOsage University Partners IISeed
$2,000,000
Funding info provided by Diffbot.
ReCode Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on ReCode Therapeutics.